German Society for Pediatric Oncology and Hematology GPOH gGmbH
16
6
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
56%
9 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Role: collaborator
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Role: collaborator
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Role: collaborator
Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)
Role: collaborator
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Role: lead
Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
Role: collaborator
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Role: collaborator
Prospective Study of Children and Adolescents With Craniopharyngioma
Role: collaborator
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Role: lead
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors
Role: collaborator
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Role: collaborator
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Role: collaborator
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
Role: lead
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Role: lead
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
Role: lead
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Role: lead
All 16 trials loaded